Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Thyrotropin receptor antibodies and a genetic hint in antithyroid drug-induced adverse drug reactions.

Expert opinion on drug safety - 1 Aug 2018

Chang Lin-Chau, Chang Chien-Ching, Chen Pei-Lung, Wang Shun-Huo, Chen Yi-Hsuan, Tsai Yung-Hsin, Shih Shyang-Rong, Chiu Wei-Yih, Fann Cathy Shen-Jang, Yang Wei-Shiung, Chang Tien-Chun

Abstract excerpt

BACKGROUND: Antithyroid drugs (ATDs) are known to cause various adverse drug reactions (ADRs) that can lead to treatment complexity and unpredictable risks. With the aim of ensuring safer drug use, we assessed whether thyrotropin receptor antibody (TRAb) titers are associated with ATD-induced cutaneous reactions and/or hepatotoxicity, and examined potential genetic predisposition factors. METHODS: We compared...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibodies
Share to Case-Control Studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Chemical and Drug Induced Liver Injury

Share to Drug Eruptions

Share to Genome-Wide Association Study

Share to Graves Disease

Share to Receptors, Thyrotropin

Share to Young Adult

Source

Identifiers

PMID: 30067105
DOI: 10.1080/14740338.2018.1502747

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Thyrotropin receptor antibodies and a genetic hint in antithyroid drug-induced adverse drug reactions.PMID 30067105Read ↗

HLA-B*38:02:01 predicts carbimazole/methimazole-induced agranulocytosis.Semantic proximity Read ↗

Severe Delayed Drug Reactions: Role of Genetics and Viral Infections.Semantic proximity Read ↗

Adverse Drug Reactions to Anti-TB Drugs: Pharmacogenomics Perspective for Identification of Host Genetic Markers.Semantic proximity Read ↗

Pharmacoepidemiology of autoimmune diseasesSemantic proximity Read ↗

Genetic determinants of antithyroid drug-induced agranulocytosis by human leukocyte antigen genotyping and genome-wide association study.Semantic proximity Read ↗

Pharmacogenomic Profile and Adverse Drug Reactions in a Prospective Therapeutic Cohort of Chagas Disease Patients Treated with Benznidazole.Semantic proximity Read ↗

Adverse drug reactions associated with the use of biological agentsSemantic proximity Read ↗

The Interplay Between Molecular Architecture, Pharmacology, and Suspected Adverse Drug Reactions Associated with Non-Steroidal Androgen Antagonists in The United KingdomSemantic proximity Read ↗

Pharmacogenomic screening strategy and indicative screening efficiency for antithyroid drug-induced agranulocytosis in the Southern Han Chinese.Semantic proximity Read ↗

Genetic variants associated with antithyroid drug-induced agranulocytosis: a genome-wide association study in a European population.Semantic proximity Read ↗

Application of Tocilizumab in Drug-Induced Liver Injury: Pharmacovigilance Study Using the FAERS Database and the Drug-Gene Interaction Network AnalysisSemantic proximity Read ↗

A real-world pharmacovigilance study of FDA adverse event reporting system (FAERS) events for TivozanibSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.